BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

All Posts


Artificial Intelligence Empowers Drug Discovery: New …

Artificial Intelligence Empowers Drug Discovery: New AI-startups Focus On Biotech

Aug. 18, 2016   by Andrii Buvailo     Artificial Intelligence
In 1997 a remarkable event caught everybody’s attention - the then champion of the world Garry Kasparov lost a tournament to …
Continue ›››
A Drug Repurposing Case By Biotech …

A Drug Repurposing Case By Biotech Startup Forty Seven Inc

July 21, 2016   by Andrii Buvailo     --
Drug repositioning is a smart and cost-effective approach used by some pharmaceutical companies to re-invent their previously successful drugs in …
Continue ›››
Cross-Coupling Hits The Big Time Again

Cross-Coupling Hits The Big Time Again

July 11, 2016   by Andrii Buvailo     --
Recently, a series of papers emerged in scientific press significantly expanding capabilities of classical carbon-heteroatom cross-coupling reactions making them simpler, …
Continue ›››
A Second Chance for Integrins: Biotech …

A Second Chance for Integrins: Biotech Startup Morphic Therapeutic Reinvents Old Target

July 5, 2016   by Andrii Buvailo     --
Integrins are a group of transmembrane receptors playing a major role in cell-cell and cell-extracellular matrix (ECM) interactions. When triggered, …
Continue ›››
What Chemicals Are Popular Among Medicinal …

What Chemicals Are Popular Among Medicinal Chemists?

June 30, 2016   by Andrii Buvailo     --
Increasing the success rate of high-throughput screening (HTS) and the quality of the resulting hits as well as developability of …
Continue ›››
Facebook and Napster founder Sean Parker …

Facebook and Napster founder Sean Parker is going to “hack cancer” by CRISPR technology

June 24, 2016   by Andrii Buvailo     --
A billionaire Sean Parker, known as a founder of Facebook and Napster, has steeply entered Life Sciences industry to fund …
Continue ›››
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.